Search

Your search keyword '"Miele, Luca"' showing total 1,034 results

Search Constraints

Start Over You searched for: Author "Miele, Luca" Remove constraint Author: "Miele, Luca"
1,034 results on '"Miele, Luca"'

Search Results

52. Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease

53. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

56. Accuracy of 100 Hz transient elastography-based spleen stiffness for the identification of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease

57. A prospective multicenter study to examine the impact of acquired and genetic predictors on Hepatocellular carcinoma risk in patients with advanced NAFLD: first report

58. Free light chains: novel serum biomarkers for NASH stratification, an update

59. Validation of elastography criteria and cACLD risk model for diagnosis of compensated advanced chronic liver disease (cACLD) in NAFLD patients

60. Urinary lithogenic profile of patients with non-alcoholic fatty liver disease

62. Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease

63. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

66. Rare ATG7 genetic variants predispose patients to severe fatty liver disease

67. Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia

68. Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy

69. Corrigendum to ‘Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)’ Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16

70. Corrigendum to “Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)” [Dig Liver Dis 54 (2022) 170–182]

71. Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation

72. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16

73. Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study

74. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' [Dig Liver Dis 54 (2022) 170-182]

75. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma

77. A “systems medicine” approach to the study of non-alcoholic fatty liver disease

78. FibroGENE: A gene-based model for staging liver fibrosis

80. Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

82. Watery stools and metabolic acidosis

85. Rare ATG7 genetic variants predispose patients to severe fatty liver disease

87. Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey

88. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease

89. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database

90. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression

91. A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19

92. The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients

93. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

94. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

97. Free Light Chains as a potential biomarker of inflammation and fibrosis in non-alcoholic steatohepatitis

98. Increased burden of inherited IRF3 rare genetic variants in Europeans with severe Non-alcoholic fatty liver diease

100. Global multi-stakeholder endorsement of the MAFLD definition

Catalog

Books, media, physical & digital resources